SC

Santhivardhan Chinni

HCL Technologies (India), Raghavendra Institute of Pharmaceutical Education, JSS University, Sree Vidyanikethan College of Pharmacy

ORCID iD 0000-0003-0774-2026
Follow

About

Authoring and reviewing literature summaries, 510(k) summaries, CEP, CER, PMCF Plan, PMCF Evaluation Report, SSCP, and PSUR/PMSR for Medical Devices | PER, SVR, APR, and CPR for Invitro Diagnostic Devices | Performing Systematic Literature Reviews, Complaint Data Analysis, Trend Reporting, and Risk-Benefit assessment | Experienced in drafting manuscripts and clinical summaries Pharmaceuticals | IRCA Certified Medical Devices QMS (ISO 13485) Lead Auditor

Employment

  • HCL Technologies (India) Lead - Medical Writer
    2021 - Present
  • Raghavendra Institute of Pharmaceutical Education Associate Professor
    2018 - 2020
  • Sree Vidyanikethan College of Pharmacy Associate Professor
    2014 - 2018
  • JSS College of Pharmacy Senior Research Fellow
    2012 - 2014

Education

  • JSS University Ph.D.
    2010 - 2014

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

  • Plausible role of combination of Chlorpromazine hydrochloride and Teicoplanin against COVID-19
    Medical Hypotheses 2020 DOI: 10.1016/j.mehy.2020.110011
    +Save
  • Effect of crude extract of Eugenia jambolana Lam. on human cytochrome P450 enzymes.
    2014
    +Save
  • Pharmacokinetics and tissue distribution of a M1 muscarinic acetylcholine receptor positive allosteric potentiator, benzyl quinolone carboxylic acid
    2014
    +Save
  • Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer's disease.
    2014
    +Save
  • Neuroprotective effect of Tinospora cordifolia ethanol extract on 6-hydroxy dopamine induced Parkinsonism
    2014
    +Save
  • A molecular connection of Pterocarpus marsupium, Eugenia jambolana and Gymnema sylvestre with dipeptidyl peptidase-4 in the treatment of diabetes.
    2014
    +Save
  • An anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin induced Alzheimer’s disease
    2013
    +Save
  • Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease.
    2013
    +Save